V. Russell

Inhaled calcium salts inhibit tobacco smoke-induced inflammation by modulating expression of chemokines and cytokines.

S. Arold, Elizabeth Berry, R. Clarke, 2018, Pulmonary pharmacology & therapeutics.

Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases.

Valentina Bagnacani, Christopher A. Hurley, P. Puccini, 2022, Journal of medicinal chemistry.

The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.

N. C. Ray, K. J. Escott, R. Bull, 2013, Bioorganic & medicinal chemistry letters.

Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment

S. Dupont, N. Desroy, R. Blanqué, 2015 .

Quantitation of hydroxyproline in a mouse model of bleomycin-induced lung fibrosis: comparison with histological analysis

J. Velden, Daniela Pompilio, F. Andreetta, 2019, Mechanisms of lung injury and repair.

The discovery of AZD9164, a novel muscarinic M3 antagonist.

Keith Bowers, Ken Grime, Helen Edwards, 2011, Bioorganic & medicinal chemistry letters.

Oral S-Nitrosoglutathione Reductase Inhibitors Attenuate Pulmonary Inflammation And Decrease Airspace Enlargement In Experimental Models Of Chronic Obstructive Pulmonary Disease

S. Mutka, G. Rosenthal, D. Drolet, 2011, ATS 2011.